WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008092231) COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/092231    International Application No.:    PCT/CA2007/000146
Publication Date: 07.08.2008 International Filing Date: 01.02.2007
IPC:
C07D 239/91 (2006.01), A61K 31/4375 (2006.01), A61K 31/472 (2006.01), A61K 31/496 (2006.01), A61K 31/517 (2006.01), A61K 31/519 (2006.01), A61K 31/5377 (2006.01), A61P 3/06 (2006.01), A61P 9/00 (2006.01), C07D 217/24 (2006.01), C07D 401/04 (2006.01), C07D 401/12 (2006.01), C07D 403/10 (2006.01), C07D 405/04 (2006.01), C07D 413/06 (2006.01), C07D 471/04 (2006.01)
Applicants: Resverlogix Corp. [CA/CA]; 202,279 Midpark Way, Calgary, Alberta T2X 1M2 (CA) (For All Designated States Except US).
HANSEN, Henrik [CA/CA]; (CA) (For US Only)
Inventors: HANSEN, Henrik; (CA)
Agent: CREBER, Anthony, G.; Gowling Lafleur Henderson LLP, 160 Elgin Street, Suite 2600, Ottawa, Ontario K1P 1C3 (CA)
Priority Data:
Title (EN) COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
(FR) COMPOSÉS DESTINÉS À LA PRÉVENTION ET AU TRAITEMENT DE MALADIES CARDIOVASCULAIRES
Abstract: front page image
(EN)The present disclosure relates to compounds, which are useful for regulating the expression of apolipoproteiπ A-I (ApoA-l), and their use for the treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.
(FR)La présente invention concerne des composés qui sont utiles dans la régulation de l'expression de l'apolipoprotéine A-I (ApoA-l), et leur utilisation pour le traitement et la prévention de maladies cardiovasculaires et d'états pathologiques associés, y compris des troubles liés au cholestérol ou aux lipides, tels que, par exemple, l'athérosclérose.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)